| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 6 |
| 1 | AMLODIPINE | 5 |
| 2 | CLOPIDOGREL | 4 |
| 3 | DEXAMETHASONE | 4 |
| 4 | DEXAMETHASONE 1.5 MG | 4 |
| 5 | ECULIZUMAB | 4 |
| 6 | ESOMEPRAZOLE MAGNESIUM | 4 |
| 7 | LANSOPRAZOLE | 4 |
| 8 | PANTOPRAZOLE | 4 |
| 9 | ADALIMUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MEGNESIUM OXIDE | 1 | 0.0024 |
| 1 | DIAZOXIDE | 1 | 0.0014 |
| 2 | PURIXAN | 1 | 0.0013 |
| 3 | NELARABINE | 1 | 0.0010 |
| 4 | CHLORPROMAZINE | 3 | 0.0005 |
| 5 | TECLISTAMAB-CQYV | 1 | 0.0004 |
| 6 | AZILSARTAN KAMEDOXOMIL | 1 | 0.0003 |
| 7 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 2 | 0.0003 |
| 8 | OFLOXACIN OTIC SOLUTION | 2 | 0.0003 |
| 9 | OFLOXACIN OPHTHALMIC SOLUTION USP, 0.3% | 2 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |
| 1 | Quinolone Antimicrobial [EPC] | 2 | 0.0002 |
| 2 | Interleukin-1 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 3 | Complement Inhibitor [EPC] | 4 | 0.0001 |
| 4 | Protease Inhibitor [EPC] | 3 | 0.0001 |
| 5 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 6 | Cytochrome P450 3A Inhibitor [EPC] | 3 | 0.0000 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 8 | Alkaloid [EPC] | 1 | 0.0000 |
| 9 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |